Biomarker testing is changing how colorectal cancer is treated, giving patients more personalized and effective care. By ...

Oncology pharmacists bridge gaps in test ordering, result interpretation, and therapy access, ensuring timely and effective ...

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Not available to all in New Jersey, biomarker testing is used to analyze samples of blood, tissue and other bodily fluids to identify specific genes, proteins and more that can indicate the presence ...

Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...

Cancer is often caused by genetic mutations, which can lead to abnormal cell growth in the body. One type is called the KRAS G12C mutation, which happens in the KRAS protein.[1] KRAS acts as the ...

BOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc. today announced it has awarded two grants to organizations working to address disparities in biomarker testing for breast and prostate cancer ...

Indias first AI-integrated blood biomarker test with PET and MRI imaging shows promises with early Alzheimers detection, safer diagnosis and timely care planning.

‘I Tried Midi Health for Biomarker Testing—Here’s What I Learned About My Health’ originally appeared on Parade. Considering that I’m a journalist, it’s not a surprise that I believe that knowledge is ...

Although treatment of advanced gastroesophageal cancer is increasingly dependent on biomarkers, only about 40% of patients are tested. For patients to fully benefit from the latest targeted therapies, ...

Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

Please provide your email address to receive an email when new articles are posted on . Biomarker testing appeared inconsistent, with rates not reflecting guidelines. Less than 25% of oncologists ...